LLY???s newest approvals and pipeline deals add fresh momentum to revenue growth as the company expands beyond its GLP-1 ...

Eli Lilly is well on its way to the trillion-dollar club. The stock price is up 30% so far this year; with a total ...

Mirikizumab (Omvoh) is effective in inducing a clinical response in adults with moderate-to-severe ulcerative colitis and ...

The discovery that a toxin made by bacteria found in dirty water might help trigger ulcerative colitis could lead to new ...

Interleukin-23 (IL-23) plays a pivotal role in the complex pathogenesis of both ulcerative colitis and Crohn's disease, making it a promising therapeutic target.1 Mirikizumab is a humanised IgG4 ...

Chinese scientists may have developed a possible alternative to colonoscopies for detecting gastrointestinal diseases with a ...

A toxin-secreting gut bacterium may fuel ulcerative colitis by killing protective immune cells that maintain intestinal homeostasis, according to a new study. The findings suggest potential for new ...

Week held in Berlin, Germany, an informative session explored emerging approaches for the management of ulcerative colitis (UC), ranging from surgical interventions to updated treatment guidelines and ...

A gut microbe secretes macrophage-targeting factors, rendering the intestinal layer vulnerable to ulcerative colitis, ...